Research and Development
iCoat Medical’s products are based on 25 years’ research and development in close collaboration with leading academic institutions. Pre-clinical studies unanimously show that iCM012 improves the kidney’s function in connection to transplantation. Initially iCM012 will be evaluated for kidneys but the ambition is that the product can be used in connection to all other types of transplantation.
iCoat Medical’s products utilize a proprietary coating technology. The coating technology enables various molecules to spontaneously enter into cell membranes and form a tight coat that prevents plasma proteins and cells from reacting with the cell surface. iCoat Medical applies this technology to specifically protect ischemic cells from attack from the innate immune system.